CymitQuimica logo
Cell Cycle/Checkpoint

Cell Cycle/Checkpoint

Cell cycle/checkpoint inhibitors are compounds that disrupt the normal progression of the cell cycle, particularly at key regulatory checkpoints. These inhibitors are crucial for studying cell division, understanding cancer cell proliferation, and developing anti-cancer therapies. By targeting specific phases of the cell cycle, these inhibitors can induce cell cycle arrest, leading to apoptosis or senescence in rapidly dividing cells. At CymitQuimica, we offer a diverse range of high-quality cell cycle/checkpoint inhibitors to support your research in cancer biology, cell biology, and drug development.

Subcategories of "Cell Cycle/Checkpoint"

Show 10 more subcategories

Found 3749 products of "Cell Cycle/Checkpoint"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • PD-1/PD-L1-IN-51


    PD-1/PD-L1-IN-51 (Compound III-4) is an inhibitor of PD-1/PD-L1 (IC50: hPD-L1 at 2.9 nM). It binds directly to PD-L1, blocking the interaction between PD-1 and PD-L1, and enhancing the release of IFN-γ. Additionally, PD-1/PD-L1-IN-51 exhibits antitumor activity.
    Color and Shape:Odour Solid
  • Orbofiban acetate

    CAS:
    Orbofiban Acetate is a compound that serves as an antagonist to the platelet GPIIb/IIIa receptor, effectively inhibiting platelet aggregation when administered
    Formula:C19H27N5O6
    Color and Shape:Solid
    Molecular weight:421.45
  • CDK4/6-IN-5

    CAS:
    <p>CDK4/6-IN-5 inhibits CDK4/6; Ki: 0.2 nM (CDK4/D1) &amp; 4.4 nM (CDK6/D3). (WO2019207463A1, A93)</p>
    Formula:C22H28ClFN6O4S
    Color and Shape:Solid
    Molecular weight:527.01
  • N3-[(Pyrid-4-yl)methyl]uridine


    N3-[(Pyrid-4-yl)methyl]uridine, a uridine analog, may have antiepileptic properties and aid in researching anticonvulsants and anxiolytics.
    Formula:C15H17N3O6
    Color and Shape:Solid
    Molecular weight:335.31
  • Ceftriaxone

    CAS:
    Ceftriaxone: cephalosporin antibiotic, effective against Gram-positive/negative bacteria, with anti-inflammatory/antioxidant properties.
    Formula:C18H18N8O7S3
    Purity:96.08%
    Color and Shape:Solid
    Molecular weight:554.58
  • T-2513

    CAS:
    T-2513 inhibits topoisomerase I by covalently bonding to its DNA complex, blocking DNA replication and causing cell death.
    Formula:C25H27N3O5
    Color and Shape:Solid
    Molecular weight:449.507
  • TTK/PLK1-IN-1

    CAS:
    TTK/PLK1-IN-1 (Formula I) is a dual inhibitor of TTK (threonine tyrosine kinase) and PLK1 (polo-like kinase 1), with IC₅₀ values of 7 nM and 72 nM respectively.
    Formula:C30H33N7O2
    Purity:97.39%
    Color and Shape:Solid
    Molecular weight:523.63
  • wrwyar-NH2 TFA


    <p>wrwyar-NH2 (TFA) serves as the control peptide for wrwycr-NH2.</p>
    Color and Shape:Odour Solid
  • m7GpppCmpG

    CAS:
    m7GpppCmpG, a trinucleotide cap analogue, enables RNA manufacturing with cap 0 or cap 1 structures.
    Formula:C31H43N13O25P4
    Color and Shape:Solid
    Molecular weight:1121.64
  • GS-443902 trisodium

    CAS:
    <p>GS-443902 trisodium, a strong RdRp blocker, inhibits RSV/HCV with IC50 of 1.1/5 μM and is Remdesivir's active form.</p>
    Formula:C12H16N5O13P3·xNa
    Color and Shape:Solid
  • DNA Gyrase-IN-12


    DNA Gyrase-IN-12 (Compound 6d) is an inhibitor of DNA gyrase. It exhibits antibacterial activity with MIC values ranging from 0.031 to 0.0625 μg/mL against Vancomycin-Intermediate Staphylococcus aureus (VISA) and Enterococcus faecium.
    Color and Shape:Odour Solid
  • CDK7-IN-2 hydrochloride hydrate

    CAS:
    CDK7-IN-2 HCl hydrate is a potent, specific CDK7 enzyme inhibitor with significant anti-cancer effects.
    Formula:C26H42ClN7O4
    Color and Shape:Solid
    Molecular weight:552.12
  • CDK7-IN-6

    CAS:
    CDK7-IN-6, a potent CDK7 inhibitor (IC50 ≤100 nM), from WO2019197549 A1, is >200x selective over CDK1/2/5, promising for cancer research.
    Formula:C26H34ClN9O
    Color and Shape:Solid
    Molecular weight:524.07
  • GK13S


    <p>G13KS: UCHL1 ligand, deubiquitinase inhibitor; reduces monoubiquitin in glioblastoma cells.</p>
    Formula:C21H22N6O2
    Color and Shape:Solid
    Molecular weight:390.44
  • IRE1-IN-2


    IRE1-IN-2 (compound G15) functions as a potent inhibitor of IRE1. It effectively suppresses lipid accumulation induced by FFA, exhibiting an IC50 value of 2.06 μM.
    Formula:C16H20O6
    Color and Shape:Solid
    Molecular weight:308.12599
  • TFMU-ADPr triethylamine


    <p>TFMU-ADPr triethylamine is a substrate for PARG activity measurement, releasing a fluorophore to indicate PAR hydrolase activity.</p>
    Formula:C25H26F3N5O16P2·5C6H15N
    Color and Shape:Solid
    Molecular weight:1024.42
  • 8-Chloro-2'-deoxy-2'-fluoro-arabino adenosine


    8-Chloro-2’-deoxy-2’-fluoro-arabino adenosine, a purine nucleoside analog, demonstrates broad antitumor activity against indolent lymphoid malignancies.
    Formula:C10H11ClFN5O3
    Color and Shape:Solid
    Molecular weight:303.68
  • YKL-5-124 TFA

    CAS:
    YKL-5-124 TFA is a potent CDK7 inhibitor (IC50: 53.5 nM), more than 100x selective over CDK9/2, not active on CDK12/13, and disrupts the cell cycle.
    Formula:C30H34F3N7O5
    Color and Shape:Solid
    Molecular weight:629.63
  • Uridine-5-oxo-acetyl-(9-fluorenylmethyl) ester


    Uridine analogue with antitumor effects; inhibits DNA synthesis, induces apoptosis in lymphoid cancers.
    Formula:C24H24N2O9
    Color and Shape:Solid
    Molecular weight:484.46
  • DENV-IN-2

    CAS:
    DENV-IN-2 inhibits dengue virus replication (EC50: 0.016 nM), affects all serotypes (EC50: 0.013-0.029 nM). Derived from WO2018215315A1 6AB.
    Formula:C29H26ClF3N2O6
    Color and Shape:Solid
    Molecular weight:590.98